This includes reduced rates of acute decompensated liver failure and alcoholic hepatitis, although, notably, no significant difference was observed in the progression to cirrhosis within the study period (Wickramarachchi et al., 2025)
Both drugs offer impressive results for weight loss and metabolic health benefits, but their high cost often makes access a challenge
While the primary endpoints appear to have been successfully met, could you clarify whether the study was powered to evaluate the secondary outcomes
How can you keep Ozempic cold while traveling
Oral Wegovy (Semaglutide Pill) Introduced in December 2025, oral Wegovy gives patients a daily pill option for weight management, combining the same reliable GLP-1 science found in its injectable form
At risk release without functional follow-through is Releasing sterile products before final testing is complete can be defensible not a quality framework